Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cysique, L. A.J.
Right arrow Articles by Brew, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cysique, L. A.J.
Right arrow Articles by Brew, B. J.
Related Collections
Right arrow HIV
Right arrow All Clinical trials
Right arrow All Neuropsychology/Behavior
Right arrow Clinical trials Observational study (Cohort, Case control)
NEUROLOGY 2006;66:1447-1450
© 2006 American Academy of Neurology
Brief Communications

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients

Lucette A.J. Cysique, PhD, Paul Maruff, PhD and Bruce J. Brew, MBBS, MD, FRACP

From the Faculty of Medicine (L.A.J.C.), St. Vincent’s Clinical School, University of New South Wales, Sydney, Australia; School of Psychology (P.M.), LaTrobe University, Melbourne, Australia; Departments of Neurology and HIV Medicine (B.J.B.), St. Vincent’s Hospital, Sydney, Australia.

Address correspondence and reprint requests to Dr. Lucette Cysique, HNRC, 150 West Washington Street, 2nd Floor, San Diego, CA 92103; e-mail: lcysique{at}ucsd.edu

The authors examined cognitive performance change in 101 individuals with advanced HIV infection on highly active antiretroviral therapy (HAART), using standard neuropsychological testing in three visits, over a 27-month-period. Cognitive performance stabilized in a majority of HIV+ participants over time. A neuroactive HAART regimen was associated with neuropsychological improvement. Decline occurred in a minority with lower nadir CD4. The current CD4 count and plasma viral load were not associated with cognitive change.

Disclosure: The authors report no conflicts of interest.

Received October 18, 2005. Accepted in final form January 23, 2006.




This article has been cited by other articles:


Home page
 NeurologyHome page
S. Tisch and B. Brew
PARKINSONISM IN HIV-INFECTED PATIENTS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
Neurology, August 4, 2009; 73(5): 401 - 403.
[Full Text] [PDF]

Home page
 NeurologyHome page
L. A. Cysique, F. Vaida, S. Letendre, S. Gibson, M. Cherner, S. P. Woods, J. A. McCutchan, R. K. Heaton, and R. J. Ellis
Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
Neurology, August 4, 2009; 73(5): 342 - 348.
[Abstract] [Full Text] [PDF]

Home page
 PsychosomaticsHome page
E. Nakimuli-Mpungu, S. Musisi, S. Kiwuwa Mpungu, and E. Katabira
Early-Onset Versus Late-Onset HIV-Related Secondary Mania in Uganda
Psychosomatics, November 1, 2008; 49(6): 530 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
S. Venneti, D. Bonneh-Barkay, B. J. Lopresti, S. J. Bissel, G. Wang, C. A. Mathis, M. Piatak Jr., J. D. Lifson, J. O. Nyaundi, M. Murphey-Corb, et al.
Longitudinal in Vivo Positron Emission Tomography Imaging of Infected and Activated Brain Macrophages in a Macaque Model of Human Immunodeficiency Virus Encephalitis Correlates with Central and Peripheral Markers of Encephalitis and Areas of Synaptic Degeneration
Am. J. Pathol., June 1, 2008; 172(6): 1603 - 1616.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.